China Regenerative Medicine International Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was HKD 64.126 million compared to HKD 5.422 million a year ago. Net loss was HKD 18.341 million compared to HKD 22.178 million a year ago. Basic loss per share from continuing operations was HKD 0.00974 compared to HKD 0.02522 a year ago. For the nine months, sales was HKD 123.563 million compared to HKD 17.040 million a year ago. Net loss was HKD 182.073 million compared to HKD 82.931 million a year ago. Basic loss per share from continuing operations was HKD 0.13676 compared to HKD 0.09432 a year ago.